(Q73119226)
Statements
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas (English)
F R Appelbaum
1 reference
J F Eary
T Gooley
S Liu
J G Rajendran
D G Maloney
S Petersdorf
S A Bush
L D Durack
P J Martin
D R Fisher
B Wood
J W Borrow
B Porter
J P Smith
D C Matthews